<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4608E704-6475-4CCA-AD08-F356E4757A3D"><gtr:id>4608E704-6475-4CCA-AD08-F356E4757A3D</gtr:id><gtr:firstName>Tracy</gtr:firstName><gtr:surname>Hussell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9286926D-0CEE-49EF-907D-AD80DB8643FE"><gtr:id>9286926D-0CEE-49EF-907D-AD80DB8643FE</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Themis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/70EFDC8E-A677-4AE3-81B3-CB197B9403FE"><gtr:id>70EFDC8E-A677-4AE3-81B3-CB197B9403FE</gtr:id><gtr:firstName>Herbert</gtr:firstName><gtr:otherNames>Terence</gtr:otherNames><gtr:surname>Cook</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DB121CC9-E948-4D1C-96D7-5B2FEB2D6B39"><gtr:id>DB121CC9-E948-4D1C-96D7-5B2FEB2D6B39</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>Coutelle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9CBA2D13-1E93-4AE3-8189-8FBE4F200993"><gtr:id>9CBA2D13-1E93-4AE3-8189-8FBE4F200993</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:otherNames>Henry</gtr:otherNames><gtr:surname>Rodeck</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ADAC772E-FC12-46CC-B329-59AB53C77609"><gtr:id>ADAC772E-FC12-46CC-B329-59AB53C77609</gtr:id><gtr:firstName>Margaret</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Dallman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AD518209-EBB2-47E6-A35F-A2DD62FA8074"><gtr:id>AD518209-EBB2-47E6-A35F-A2DD62FA8074</gtr:id><gtr:firstName>Richard William</gtr:firstName><gtr:surname>Titball</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8B8521BF-0532-4219-A743-8C796C76D2CA"><gtr:id>8B8521BF-0532-4219-A743-8C796C76D2CA</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Huxley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F9BEDA02-4E7D-4755-A68A-A0082F82EA03"><gtr:id>F9BEDA02-4E7D-4755-A68A-A0082F82EA03</gtr:id><gtr:firstName>Miguel</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Seabra</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4B8CE3D7-F08E-4A54-BA5B-796A99203E0E"><gtr:id>4B8CE3D7-F08E-4A54-BA5B-796A99203E0E</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Lloyd</gtr:surname><gtr:orcidId>0000-0001-8977-6726</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9805886"><gtr:id>D2E94E61-F130-45F8-BAED-078D96C80D03</gtr:id><gtr:title>Animal models to study human disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9805886</gtr:grantReference><gtr:abstractText>The Co-operative Animal models to study human disease is a group of nine research laboratories trying to understand and treat a variety of genetic diseases including cystic fibrosis, asthma, blood and neuroretinal degenerative diseases. Although the diseases are quite different in how they affect patients, they are all caused by underlying mutations in the DNA which can be inherited in families, and they are studied using the same laboratory techniques. The first step in understanding a genetic disease is to genetically map it to a specific part of the total human DNA and to identify the actual gene which ahs the mutations. This has been done for these diseases. The disease can then be studied using cells in culture, which can give a lot of information about what is actually wrong with the cells. However, for many diseases, especially ones affecting very defined tissues of the body such as the retina in eye diseases or epithelia in cystic fibrosis, only a limited amount of information can be gained using cultured cells. Therefore, we will use animal models of these human diseases. The affected animals, usually mice are then used to study the disease, which involved taking tissues from the mice at different stages of development and after treatment with potentially therapeutic drugs. As the basic defect in all these disorders is mutation in the DNA, they can all potentially be treated by gene therapy which is the addition of the correct DNA to the cells of the body, which are affected by the disease. This group of scientists is developing methods for DNA delivery which are suitable for the specific diseases being studied; for instance delivery to the lung for cystic fibrosis and to the neurons for ataxia. The final aim of the research is to develop effective treatments for cystic fibrosis, asthma, some forms of blindness and neurodegenerative diseases. The results of our research and their relevance to the development of novel therapeutic approaches as well as their ethical implications will be widely publicised in meetings and scientific articles</gtr:abstractText><gtr:technicalSummary>The aim of the Co-operative is to provide the scientific environment to enable top-notch research using animal models to study human diseases. Mouse models are crucial to study disease processes at the tissue and organ levels, for cell and molecular studies on differentiated cell types for which there are no suitable tissue culture systems and for in vivo assessment of gene therapy approaches. These studies require a large amount of expertise, facilities and equipment, which is beyond the ability of single groups. This co-operative will provide for part of the funding necessary to underpin the common aspects of the research. It will provide the basis for sharing facilities such as dedicated areas and the equipment necessary for production of transgenic mice and rederivation of mouse lines, and gene delivery into animals. Scientifically, the Co-operative will foster the collaborations necessary to provide the width and depth of expertise necessary for internationally-competitive work with animal models of disease and for therapeutic intervention. The groups participating in the co-operative are, all but one, part of Imperial College London and work in, or collaborate with groups who work in, the Sir Alexander Fleming Building at the main South Kensington campus. The Co-operative represents the focus for animal modelling and gene therapy research in this campus.</gtr:technicalSummary><gtr:fund><gtr:end>2008-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>309266</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>2D0291C8-6F2A-4DB4-951C-A359013BE23A</gtr:id><gtr:impact>The team get invited to secondary schools on a regular basis to speak with 6th formers, their teachers and parents.

Public awareness</gtr:impact><gtr:outcomeId>FA66DECACE2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press attention</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>1F56EB2C-4DD9-4029-85B6-5DA826C159C6</gtr:id><gtr:impact>The gene therapy work received press attention, with articles featured in &amp;quot;The Times&amp;quot; and &amp;quot;Daily telegraph&amp;quot;. Additionally, it was featured in the MRC annual review.

Information and awareness of general public.</gtr:impact><gtr:outcomeId>F423984F756</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Choroideremia patients and families</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>4D4522B2-A4E1-4C01-9A4E-748F5AC8CED0</gtr:id><gtr:impact>The Choroideremia work attracts patients and families to visit the lab on a regular basis to interact with the sicentists and get regular updates on the work being done.

Patients feel a part of the study.</gtr:impact><gtr:outcomeId>915FE0EB6DD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC documentary</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>55F4FA0D-BC3E-436D-9758-02C6DEE68EDB</gtr:id><gtr:impact>The toxin work contributed to a BBC documentary called &amp;quot;Tetanus kill or cure&amp;quot;.

General public awareness.</gtr:impact><gtr:outcomeId>56C6DE6D854</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>271260</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Molecular Pathogenesis of Choroideremia: the role of Rab GTPases in the retinal pigment epithelium)</gtr:description><gtr:end>2009-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2360B8EA-B050-4698-8DD4-FBE51D9FE431</gtr:id><gtr:outcomeId>90DFE4C76C20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>410848</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (Mechanisms of phagocytosis in the retinal pigment epithelium)</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>737324CB-21BA-4476-984E-D453062337E7</gtr:id><gtr:outcomeId>E32A371E6F20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>130000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FFB funding (Gene therapy in mouse models of choroideremia)</gtr:description><gtr:end>2009-04-02</gtr:end><gtr:fundingOrg>Foundation Fighting Blindness (FFB)</gtr:fundingOrg><gtr:id>51C34761-F776-4E5E-9CB1-2AD898E00D56</gtr:id><gtr:outcomeId>3C64023F6640</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>358564</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant (Structure/function analysis of Rab- and Myosin-interacting proteins in organelle motility)</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>9E0C313D-BFED-457C-AC57-10B882870A9D</gtr:id><gtr:outcomeId>D2VPfcYoSnP0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>AAV-based gene therapy vector containing the CHM/REP1 gene</gtr:description><gtr:id>0DA48E79-F4DC-4B78-B3E2-651F836931AA</gtr:id><gtr:impact>Application for phase I clinical trial under review</gtr:impact><gtr:outcomeId>59EBD140E82</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>CHM</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:url>http://clinicaltrials.gov/ct2/show/NCT01461213?term=NCT01461213&amp;rank=1</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New models of Choroideremia, an X-linked retinal degeneration</gtr:description><gtr:id>CAD9F334-D69E-41CF-A874-49187E39BBB6</gtr:id><gtr:impact>Peer-reviewed publications, insoghts into disease mechanisms and application to begin phase I gene therapy clinical trials</gtr:impact><gtr:outcomeId>C0461D435CE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CHM</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>SMAR-based vectors for non-viral gene therapy</gtr:description><gtr:id>19B44931-E39E-4082-A443-4A01634E85B9</gtr:id><gtr:impact>Persistently expressing vectors that may be useful for non-viral gene therapy</gtr:impact><gtr:outcomeId>B9A5C5AB111</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SMAR</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>27C37FD8-AB00-4377-B150-22EBC6329AB3</gtr:id><gtr:title>Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1893f22f51ac65702850b328f0b98bef"><gtr:id>1893f22f51ac65702850b328f0b98bef</gtr:id><gtr:otherNames>Vaysse L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>B179D6E0B71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67BF1C2C-674F-458F-862A-CE8BFED5BC6D</gtr:id><gtr:title>Rab27a targeting to melanosomes requires nucleotide exchange but not effector binding.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf6d1d87d11e9975026d3fe9d953036c"><gtr:id>bf6d1d87d11e9975026d3fe9d953036c</gtr:id><gtr:otherNames>Tarafder AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>pm_16555_25_21554507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12ACD349-A0D0-4008-9C58-A48FAC9AA3F5</gtr:id><gtr:title>Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: toward prenatal prevention of early-onset intestinal diseases.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf121bcc34f51c5a57fdf14d4642bc0"><gtr:id>ccf121bcc34f51c5a57fdf14d4642bc0</gtr:id><gtr:otherNames>David AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>C4BD6ECF5A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3874F82E-D668-4758-A3E0-00C8F3DA255A</gtr:id><gtr:title>Ultrasound-guided injection and occlusion of the trachea in fetal sheep.</gtr:title><gtr:parentPublicationTitle>Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf121bcc34f51c5a57fdf14d4642bc0"><gtr:id>ccf121bcc34f51c5a57fdf14d4642bc0</gtr:id><gtr:otherNames>David AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0960-7692</gtr:issn><gtr:outcomeId>FC3905A463D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0269AA5B-7C4D-4D7D-9FBF-0081E61ED024</gtr:id><gtr:title>Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1893f22f51ac65702850b328f0b98bef"><gtr:id>1893f22f51ac65702850b328f0b98bef</gtr:id><gtr:otherNames>Vaysse L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FB74CF6BBBE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3249FD67-FB19-4F34-A8FA-D01ACA84D01E</gtr:id><gtr:title>Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13755ddeb34bad7bc8a30f96f16b6922"><gtr:id>13755ddeb34bad7bc8a30f96f16b6922</gtr:id><gtr:otherNames>Jancic C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>C7D5CCAFC84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8CB79E1-9812-4C34-8E95-4C59F9D3B2AD</gtr:id><gtr:title>RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia coli strain for Cre mediated production of minicircle DNA.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6b934125a1682dce74076115330a1a"><gtr:id>0e6b934125a1682dce74076115330a1a</gtr:id><gtr:otherNames>Tolmachov O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>B3ADF6789C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D916F4F-77AF-4622-B3AC-87FF9C70C67E</gtr:id><gtr:title>The gunmetal mouse reveals Rab geranylgeranyl transferase to be the major molecular target of phosphonocarboxylate analogues of bisphosphonates.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98b269f304b6a5d237101e0dc6114e4f"><gtr:id>98b269f304b6a5d237101e0dc6114e4f</gtr:id><gtr:otherNames>Coxon FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_16555_25_21419243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1BBDD4D-C26C-4080-8834-58801EB305AB</gtr:id><gtr:title>Rab27b regulates exocytosis of secretory vesicles in acinar epithelial cells from the lacrimal gland.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc0d3259d66bbd6a0753f13ada7b0aa0"><gtr:id>dc0d3259d66bbd6a0753f13ada7b0aa0</gtr:id><gtr:otherNames>Chiang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>pm_16555_25_21525430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E2761E3-C5FE-45EA-B5BF-41E1A4BA6E6B</gtr:id><gtr:title>PtdIns3P and Rac direct the assembly of the NADPH oxidase on a novel, pre-phagosomal compartment during FcR-mediated phagocytosis in primary mouse neutrophils.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b69f958d0a381f3030849518250d3521"><gtr:id>b69f958d0a381f3030849518250d3521</gtr:id><gtr:otherNames>Anderson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_16555_25_20813901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF3A52D-6D97-4DDF-A7FC-0A12D54D9771</gtr:id><gtr:title>Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c97680faf9bd93b5fe8d5a65f85ac8af"><gtr:id>c97680faf9bd93b5fe8d5a65f85ac8af</gtr:id><gtr:otherNames>Tolmachova T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>863B18E26A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83499B9E-BA72-48E9-8B98-9114483CD193</gtr:id><gtr:title>CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c97680faf9bd93b5fe8d5a65f85ac8af"><gtr:id>c97680faf9bd93b5fe8d5a65f85ac8af</gtr:id><gtr:otherNames>Tolmachova T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>pm_16555_25_22228595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E02CA9D1-06D3-4CD7-AB05-8E738E98935E</gtr:id><gtr:title>Luciferin detection after intranasal vector delivery is improved by intranasal rather than intraperitoneal luciferin administration.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb51617ff48dc2c2df156e38a48f7078"><gtr:id>eb51617ff48dc2c2df156e38a48f7078</gtr:id><gtr:otherNames>Buckley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>D1F30813BB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23DF2659-F76D-46EA-AE57-DDA0270345A5</gtr:id><gtr:title>Loss of Rab27 function results in abnormal lung epithelium structure in mice.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf890a37068893be5c32d9547f000c16"><gtr:id>bf890a37068893be5c32d9547f000c16</gtr:id><gtr:otherNames>Bolasco G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>pm_16555_25_21160031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4030A028-8267-4C30-AB97-13F3754F9A54</gtr:id><gtr:title>Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb51617ff48dc2c2df156e38a48f7078"><gtr:id>eb51617ff48dc2c2df156e38a48f7078</gtr:id><gtr:otherNames>Buckley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>425945C05C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A03A0AD1-7F34-41AA-9909-81E587FB347F</gtr:id><gtr:title>Strategies for the episomal modification of cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in molecular therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf3c4e446c514870be86286f3e93b102"><gtr:id>cf3c4e446c514870be86286f3e93b102</gtr:id><gtr:otherNames>Wong SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1464-8431</gtr:issn><gtr:outcomeId>74745981EFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBFD15CC-08BE-41B1-BB6F-ECCC47C436F4</gtr:id><gtr:title>Synthesis and application of integrin targeting lipopeptides in targeted gene delivery.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdb219eada82ebc6f86acb14980d141d"><gtr:id>bdb219eada82ebc6f86acb14980d141d</gtr:id><gtr:otherNames>Waterhouse JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>3F044F68B89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F93CE6B-ABB1-47FB-AB3C-9B4233B56903</gtr:id><gtr:title>Covalent attachment of multifunctional chimeric terminal proteins to 5' DNA ends: A potential new strategy for assembly of synthetic therapeutic gene vectors.</gtr:title><gtr:parentPublicationTitle>Medical hypotheses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6b934125a1682dce74076115330a1a"><gtr:id>0e6b934125a1682dce74076115330a1a</gtr:id><gtr:otherNames>Tolmachov O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0306-9877</gtr:issn><gtr:outcomeId>1E01C2BF767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404C6DF8-AA1C-4B28-A4DD-2BE3ECB75983</gtr:id><gtr:title>Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f056c409aede7073750d20c637e7b07f"><gtr:id>f056c409aede7073750d20c637e7b07f</gtr:id><gtr:otherNames>Hibbitt OC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>1B2365E35C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC5A4EBF-29D6-4E83-BFD3-52EF90FFD212</gtr:id><gtr:title>Rab27b regulates number and secretion of platelet dense granules.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c97680faf9bd93b5fe8d5a65f85ac8af"><gtr:id>c97680faf9bd93b5fe8d5a65f85ac8af</gtr:id><gtr:otherNames>Tolmachova T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>590659A5ACC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFB0E70-FF81-46A2-BE21-CBABB1B9DDA6</gtr:id><gtr:title>Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f34f6595a51e0ebb083644c167a286c"><gtr:id>8f34f6595a51e0ebb083644c167a286c</gtr:id><gtr:otherNames>Argyros O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>F24D7C11CC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE960C32-E748-498E-898E-22FE6CA9D108</gtr:id><gtr:title>Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb51617ff48dc2c2df156e38a48f7078"><gtr:id>eb51617ff48dc2c2df156e38a48f7078</gtr:id><gtr:otherNames>Buckley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>F5CB4AF0FA9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC038CA3-ED58-4406-8AB7-7071180797DE</gtr:id><gtr:title>Rab27b regulates mast cell granule dynamics and secretion.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445070d9d72afe2bf665a5d34684f1b5"><gtr:id>445070d9d72afe2bf665a5d34684f1b5</gtr:id><gtr:otherNames>Mizuno K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>7E035CEFD8A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9805886</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>